Biomarin Pharmaceutical (BMRN) Retained Earnings: 2009-2025
Historic Retained Earnings for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Sep 2025 value amounting to $200.8 million.
- Biomarin Pharmaceutical's Retained Earnings rose 162.81% to $200.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.8 million, marking a year-over-year increase of 162.81%. This contributed to the annual value of -$194.7 million for FY2024, which is 68.68% up from last year.
- Biomarin Pharmaceutical's Retained Earnings amounted to $200.8 million in Q3 2025, which was down 13.28% from $231.5 million recorded in Q2 2025.
- Biomarin Pharmaceutical's 5-year Retained Earnings high stood at $231.5 million for Q2 2025, and its period low was -$930.8 million during Q4 2021.
- In the last 3 years, Biomarin Pharmaceutical's Retained Earnings had a median value of -$425.7 million in 2024 and averaged -$336.9 million.
- Its Retained Earnings has fluctuated over the past 5 years, first declined by 8.03% in 2021, then skyrocketed by 162.81% in 2025.
- Biomarin Pharmaceutical's Retained Earnings (Quarterly) stood at -$930.8 million in 2021, then climbed by 15.21% to -$789.2 million in 2022, then rose by 21.24% to -$621.6 million in 2023, then skyrocketed by 68.68% to -$194.7 million in 2024, then soared by 162.81% to $200.8 million in 2025.
- Its last three reported values are $200.8 million in Q3 2025, $231.5 million for Q2 2025, and $19.2 million during Q1 2025.